IMS Health HoldingsInc. unit IMS Health Inc. completed the and sale of $1.75 billion equivalentin gross proceeds of senior notes, consisting of $1.05 billion of U.S.-dollar-denominatednotes and €625 million of euro-denominated notes.
The U.S.-dollar-denominatednotes will mature Oct. 15, 2026, and will bear interest at 5.000% per year. Theeuro-denominated notes will mature Oct. 15, 2024, and will bear interest at3.500% per year.
Interest on the notes ispayable semiannually on April 15 and Oct. 15 of each year, starting April 15,2017.